ClinicalTrials.gov
ClinicalTrials.gov Menu

Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00003754
Recruitment Status : Completed
First Posted : April 9, 2004
Last Update Posted : June 26, 2013
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Memorial Sloan Kettering Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2001
  Actual Study Completion Date : July 2001